nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—Heart malformation—Cisplatin—esophageal cancer	0.0418	0.0628	CcSEcCtD
Ropivacaine—Postoperative complications NOS—Capecitabine—esophageal cancer	0.0349	0.0524	CcSEcCtD
Ropivacaine—Heart disease congenital—Cisplatin—esophageal cancer	0.0342	0.0513	CcSEcCtD
Ropivacaine—Post procedural complication—Capecitabine—esophageal cancer	0.0308	0.0463	CcSEcCtD
Ropivacaine—Cranial nerve paralysis—Methotrexate—esophageal cancer	0.0188	0.0282	CcSEcCtD
Ropivacaine—CNS toxicity—Methotrexate—esophageal cancer	0.0188	0.0282	CcSEcCtD
Ropivacaine—Prothrombin level decreased—Capecitabine—esophageal cancer	0.0152	0.0228	CcSEcCtD
Ropivacaine—Neurological symptom—Cisplatin—esophageal cancer	0.0131	0.0196	CcSEcCtD
Ropivacaine—Meningism—Methotrexate—esophageal cancer	0.0125	0.0187	CcSEcCtD
Ropivacaine—Arachnoiditis—Methotrexate—esophageal cancer	0.0119	0.0178	CcSEcCtD
Ropivacaine—Phlebitis—Carboplatin—esophageal cancer	0.0113	0.017	CcSEcCtD
Ropivacaine—Neurotoxicity—Cisplatin—esophageal cancer	0.0102	0.0153	CcSEcCtD
Ropivacaine—Vasospasm—Capecitabine—esophageal cancer	0.00851	0.0128	CcSEcCtD
Ropivacaine—Neurotoxicity—Capecitabine—esophageal cancer	0.0075	0.0113	CcSEcCtD
Ropivacaine—Rales—Capecitabine—esophageal cancer	0.00709	0.0106	CcSEcCtD
Ropivacaine—Proctalgia—Capecitabine—esophageal cancer	0.0062	0.0093	CcSEcCtD
Ropivacaine—Paresis—Methotrexate—esophageal cancer	0.00593	0.0089	CcSEcCtD
Ropivacaine—Pneumothorax—Capecitabine—esophageal cancer	0.00584	0.00877	CcSEcCtD
Ropivacaine—Neurotoxicity—Methotrexate—esophageal cancer	0.00558	0.00838	CcSEcCtD
Ropivacaine—Rales—Methotrexate—esophageal cancer	0.00528	0.00792	CcSEcCtD
Ropivacaine—Sneezing—Capecitabine—esophageal cancer	0.00525	0.00788	CcSEcCtD
Ropivacaine—Lidocaine—EGFR—esophageal cancer	0.00486	0.472	CrCbGaD
Ropivacaine—Deep vein thrombosis—Capecitabine—esophageal cancer	0.00478	0.00717	CcSEcCtD
Ropivacaine—Infection—Carboplatin—esophageal cancer	0.00477	0.00715	CcSEcCtD
Ropivacaine—Hypomagnesaemia—Capecitabine—esophageal cancer	0.00458	0.00687	CcSEcCtD
Ropivacaine—Dysarthria—Cisplatin—esophageal cancer	0.00417	0.00626	CcSEcCtD
Ropivacaine—Ileus—Capecitabine—esophageal cancer	0.00411	0.00616	CcSEcCtD
Ropivacaine—Pain—Carboplatin—esophageal cancer	0.0041	0.00616	CcSEcCtD
Ropivacaine—Lidocaine—CYP2A6—esophageal cancer	0.00397	0.385	CrCbGaD
Ropivacaine—Hyperkalaemia—Cisplatin—esophageal cancer	0.00387	0.00581	CcSEcCtD
Ropivacaine—Pleural effusion—Capecitabine—esophageal cancer	0.0038	0.0057	CcSEcCtD
Ropivacaine—Ventricular fibrillation—Capecitabine—esophageal cancer	0.0038	0.0057	CcSEcCtD
Ropivacaine—Body temperature increased—Carboplatin—esophageal cancer	0.00379	0.00569	CcSEcCtD
Ropivacaine—Neuropathy—Cisplatin—esophageal cancer	0.0037	0.00556	CcSEcCtD
Ropivacaine—Rigors—Capecitabine—esophageal cancer	0.00356	0.00534	CcSEcCtD
Ropivacaine—Injection site pain—Capecitabine—esophageal cancer	0.00356	0.00534	CcSEcCtD
Ropivacaine—Deep vein thrombosis—Methotrexate—esophageal cancer	0.00356	0.00534	CcSEcCtD
Ropivacaine—Extrasystoles—Capecitabine—esophageal cancer	0.00346	0.00518	CcSEcCtD
Ropivacaine—Hypoxia—Methotrexate—esophageal cancer	0.00341	0.00511	CcSEcCtD
Ropivacaine—Phlebitis—Cisplatin—esophageal cancer	0.00332	0.00499	CcSEcCtD
Ropivacaine—Hypocalcaemia—Capecitabine—esophageal cancer	0.00318	0.00477	CcSEcCtD
Ropivacaine—Paralysis—Methotrexate—esophageal cancer	0.00312	0.00467	CcSEcCtD
Ropivacaine—Dysarthria—Capecitabine—esophageal cancer	0.00307	0.00461	CcSEcCtD
Ropivacaine—Amnesia—Cisplatin—esophageal cancer	0.00305	0.00457	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00296	0.00444	CcSEcCtD
Ropivacaine—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00291	0.00436	CcSEcCtD
Ropivacaine—Pulmonary embolism—Capecitabine—esophageal cancer	0.00291	0.00436	CcSEcCtD
Ropivacaine—Stupor—Methotrexate—esophageal cancer	0.0029	0.00435	CcSEcCtD
Ropivacaine—Injection site reaction—Capecitabine—esophageal cancer	0.00289	0.00434	CcSEcCtD
Ropivacaine—Pleural effusion—Methotrexate—esophageal cancer	0.00283	0.00424	CcSEcCtD
Ropivacaine—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00281	0.00421	CcSEcCtD
Ropivacaine—Urinary incontinence—Capecitabine—esophageal cancer	0.00281	0.00421	CcSEcCtD
Ropivacaine—Neuropathy—Capecitabine—esophageal cancer	0.00273	0.0041	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00261	0.00392	CcSEcCtD
Ropivacaine—Hypokalaemia—Cisplatin—esophageal cancer	0.00261	0.00391	CcSEcCtD
Ropivacaine—Breast disorder—Cisplatin—esophageal cancer	0.00259	0.00388	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00258	0.00387	CcSEcCtD
Ropivacaine—Cramp muscle—Cisplatin—esophageal cancer	0.00258	0.00387	CcSEcCtD
Ropivacaine—Apnoea—Methotrexate—esophageal cancer	0.00255	0.00383	CcSEcCtD
Ropivacaine—Phlebitis—Capecitabine—esophageal cancer	0.00245	0.00368	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00243	0.00364	CcSEcCtD
Ropivacaine—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00241	0.00362	CcSEcCtD
Ropivacaine—Sweating increased—Cisplatin—esophageal cancer	0.00241	0.00362	CcSEcCtD
Ropivacaine—Vascular purpura—Capecitabine—esophageal cancer	0.00236	0.00354	CcSEcCtD
Ropivacaine—Oliguria—Methotrexate—esophageal cancer	0.00235	0.00352	CcSEcCtD
Ropivacaine—Dysarthria—Methotrexate—esophageal cancer	0.00229	0.00343	CcSEcCtD
Ropivacaine—Amnesia—Capecitabine—esophageal cancer	0.00225	0.00337	CcSEcCtD
Ropivacaine—Atrial fibrillation—Capecitabine—esophageal cancer	0.00223	0.00334	CcSEcCtD
Ropivacaine—Respiratory failure—Methotrexate—esophageal cancer	0.0022	0.00331	CcSEcCtD
Ropivacaine—Purpura—Capecitabine—esophageal cancer	0.00219	0.00329	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00217	0.00326	CcSEcCtD
Ropivacaine—Pulmonary embolism—Methotrexate—esophageal cancer	0.00216	0.00325	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00216	0.00325	CcSEcCtD
Ropivacaine—Myocardial infarction—Cisplatin—esophageal cancer	0.00216	0.00325	CcSEcCtD
Ropivacaine—Osteoarthritis—Capecitabine—esophageal cancer	0.00211	0.00317	CcSEcCtD
Ropivacaine—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00209	0.00314	CcSEcCtD
Ropivacaine—Bradycardia—Cisplatin—esophageal cancer	0.00202	0.00303	CcSEcCtD
Ropivacaine—Cardiac arrest—Capecitabine—esophageal cancer	0.00201	0.00301	CcSEcCtD
Ropivacaine—Urinary retention—Capecitabine—esophageal cancer	0.00201	0.00301	CcSEcCtD
Ropivacaine—Mood swings—Capecitabine—esophageal cancer	0.002	0.003	CcSEcCtD
Ropivacaine—Coma—Methotrexate—esophageal cancer	0.00198	0.00297	CcSEcCtD
Ropivacaine—Urinary tract disorder—Cisplatin—esophageal cancer	0.00196	0.00294	CcSEcCtD
Ropivacaine—Urethral disorder—Cisplatin—esophageal cancer	0.00194	0.00291	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00193	0.00289	CcSEcCtD
Ropivacaine—Hypokalaemia—Capecitabine—esophageal cancer	0.00192	0.00288	CcSEcCtD
Ropivacaine—Breast disorder—Capecitabine—esophageal cancer	0.00191	0.00286	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.0019	0.00285	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00186	0.00279	CcSEcCtD
Ropivacaine—Tinnitus—Cisplatin—esophageal cancer	0.00185	0.00277	CcSEcCtD
Ropivacaine—Cardiac disorder—Cisplatin—esophageal cancer	0.00184	0.00276	CcSEcCtD
Ropivacaine—Abdominal distension—Capecitabine—esophageal cancer	0.00184	0.00276	CcSEcCtD
Ropivacaine—Bronchospasm—Capecitabine—esophageal cancer	0.00179	0.00269	CcSEcCtD
Ropivacaine—Sweating increased—Capecitabine—esophageal cancer	0.00178	0.00267	CcSEcCtD
Ropivacaine—Arrhythmia—Cisplatin—esophageal cancer	0.00177	0.00265	CcSEcCtD
Ropivacaine—Erythema—Cisplatin—esophageal cancer	0.00172	0.00259	CcSEcCtD
Ropivacaine—Dysuria—Capecitabine—esophageal cancer	0.00171	0.00256	CcSEcCtD
Ropivacaine—Muscle spasms—Cisplatin—esophageal cancer	0.00166	0.00249	CcSEcCtD
Ropivacaine—Hyperglycaemia—Capecitabine—esophageal cancer	0.00165	0.00247	CcSEcCtD
Ropivacaine—Vision blurred—Cisplatin—esophageal cancer	0.00162	0.00244	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00162	0.00244	CcSEcCtD
Ropivacaine—Depression—Capecitabine—esophageal cancer	0.00162	0.00243	CcSEcCtD
Ropivacaine—Tremor—Cisplatin—esophageal cancer	0.00162	0.00242	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.0016	0.00241	CcSEcCtD
Ropivacaine—Ill-defined disorder—Cisplatin—esophageal cancer	0.0016	0.0024	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00159	0.00239	CcSEcCtD
Ropivacaine—Myocardial infarction—Capecitabine—esophageal cancer	0.00159	0.00239	CcSEcCtD
Ropivacaine—Anaemia—Cisplatin—esophageal cancer	0.00159	0.00239	CcSEcCtD
Ropivacaine—Jaundice—Capecitabine—esophageal cancer	0.00159	0.00238	CcSEcCtD
Ropivacaine—Urinary tract infection—Capecitabine—esophageal cancer	0.00158	0.00237	CcSEcCtD
Ropivacaine—Osteoarthritis—Methotrexate—esophageal cancer	0.00157	0.00236	CcSEcCtD
Ropivacaine—Malaise—Cisplatin—esophageal cancer	0.00155	0.00233	CcSEcCtD
Ropivacaine—Haematuria—Capecitabine—esophageal cancer	0.00155	0.00233	CcSEcCtD
Ropivacaine—Convulsion—Cisplatin—esophageal cancer	0.00149	0.00224	CcSEcCtD
Ropivacaine—Mood swings—Methotrexate—esophageal cancer	0.00149	0.00223	CcSEcCtD
Ropivacaine—Bradycardia—Capecitabine—esophageal cancer	0.00149	0.00223	CcSEcCtD
Ropivacaine—Lidocaine—ABCB1—esophageal cancer	0.00148	0.143	CrCbGaD
Ropivacaine—Myalgia—Cisplatin—esophageal cancer	0.00147	0.0022	CcSEcCtD
Ropivacaine—Rhinitis—Capecitabine—esophageal cancer	0.00146	0.0022	CcSEcCtD
Ropivacaine—Anxiety—Cisplatin—esophageal cancer	0.00146	0.00219	CcSEcCtD
Ropivacaine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00145	0.00218	CcSEcCtD
Ropivacaine—Discomfort—Cisplatin—esophageal cancer	0.00145	0.00218	CcSEcCtD
Ropivacaine—Urinary tract disorder—Capecitabine—esophageal cancer	0.00144	0.00216	CcSEcCtD
Ropivacaine—Oedema peripheral—Capecitabine—esophageal cancer	0.00144	0.00216	CcSEcCtD
Ropivacaine—Urethral disorder—Capecitabine—esophageal cancer	0.00143	0.00215	CcSEcCtD
Ropivacaine—Breast disorder—Methotrexate—esophageal cancer	0.00142	0.00213	CcSEcCtD
Ropivacaine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00141	0.00211	CcSEcCtD
Ropivacaine—Infection—Cisplatin—esophageal cancer	0.0014	0.0021	CcSEcCtD
Ropivacaine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00138	0.00207	CcSEcCtD
Ropivacaine—Tachycardia—Cisplatin—esophageal cancer	0.00137	0.00206	CcSEcCtD
Ropivacaine—Skin disorder—Cisplatin—esophageal cancer	0.00137	0.00205	CcSEcCtD
Ropivacaine—Tinnitus—Capecitabine—esophageal cancer	0.00136	0.00204	CcSEcCtD
Ropivacaine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00136	0.00204	CcSEcCtD
Ropivacaine—Cardiac disorder—Capecitabine—esophageal cancer	0.00135	0.00203	CcSEcCtD
Ropivacaine—Hypotension—Cisplatin—esophageal cancer	0.00131	0.00197	CcSEcCtD
Ropivacaine—Chills—Capecitabine—esophageal cancer	0.00131	0.00197	CcSEcCtD
Ropivacaine—Arrhythmia—Capecitabine—esophageal cancer	0.0013	0.00196	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00128	0.00192	CcSEcCtD
Ropivacaine—Mental disorder—Capecitabine—esophageal cancer	0.00128	0.00192	CcSEcCtD
Ropivacaine—Erythema—Capecitabine—esophageal cancer	0.00127	0.00191	CcSEcCtD
Ropivacaine—Dysuria—Methotrexate—esophageal cancer	0.00127	0.00191	CcSEcCtD
Ropivacaine—Paraesthesia—Cisplatin—esophageal cancer	0.00126	0.0019	CcSEcCtD
Ropivacaine—Dyspnoea—Cisplatin—esophageal cancer	0.00125	0.00188	CcSEcCtD
Ropivacaine—Back pain—Capecitabine—esophageal cancer	0.00123	0.00184	CcSEcCtD
Ropivacaine—Muscle spasms—Capecitabine—esophageal cancer	0.00122	0.00183	CcSEcCtD
Ropivacaine—Drowsiness—Methotrexate—esophageal cancer	0.00121	0.00182	CcSEcCtD
Ropivacaine—Depression—Methotrexate—esophageal cancer	0.00121	0.00181	CcSEcCtD
Ropivacaine—Pain—Cisplatin—esophageal cancer	0.0012	0.00181	CcSEcCtD
Ropivacaine—Vision blurred—Capecitabine—esophageal cancer	0.0012	0.0018	CcSEcCtD
Ropivacaine—Tremor—Capecitabine—esophageal cancer	0.00119	0.00179	CcSEcCtD
Ropivacaine—Ill-defined disorder—Capecitabine—esophageal cancer	0.00118	0.00177	CcSEcCtD
Ropivacaine—Anaemia—Capecitabine—esophageal cancer	0.00117	0.00176	CcSEcCtD
Ropivacaine—Feeling abnormal—Cisplatin—esophageal cancer	0.00116	0.00174	CcSEcCtD
Ropivacaine—Haematuria—Methotrexate—esophageal cancer	0.00115	0.00173	CcSEcCtD
Ropivacaine—Malaise—Capecitabine—esophageal cancer	0.00115	0.00172	CcSEcCtD
Ropivacaine—Vertigo—Capecitabine—esophageal cancer	0.00114	0.00171	CcSEcCtD
Ropivacaine—Syncope—Capecitabine—esophageal cancer	0.00114	0.00171	CcSEcCtD
Ropivacaine—Loss of consciousness—Capecitabine—esophageal cancer	0.00112	0.00168	CcSEcCtD
Ropivacaine—Body temperature increased—Cisplatin—esophageal cancer	0.00111	0.00167	CcSEcCtD
Ropivacaine—Cough—Capecitabine—esophageal cancer	0.00111	0.00166	CcSEcCtD
Ropivacaine—Hypertension—Capecitabine—esophageal cancer	0.0011	0.00165	CcSEcCtD
Ropivacaine—Chest pain—Capecitabine—esophageal cancer	0.00108	0.00162	CcSEcCtD
Ropivacaine—Myalgia—Capecitabine—esophageal cancer	0.00108	0.00162	CcSEcCtD
Ropivacaine—Arthralgia—Capecitabine—esophageal cancer	0.00108	0.00162	CcSEcCtD
Ropivacaine—Anxiety—Capecitabine—esophageal cancer	0.00108	0.00162	CcSEcCtD
Ropivacaine—Urinary tract disorder—Methotrexate—esophageal cancer	0.00107	0.00161	CcSEcCtD
Ropivacaine—Discomfort—Capecitabine—esophageal cancer	0.00107	0.0016	CcSEcCtD
Ropivacaine—Urethral disorder—Methotrexate—esophageal cancer	0.00107	0.0016	CcSEcCtD
Ropivacaine—Confusional state—Capecitabine—esophageal cancer	0.00105	0.00157	CcSEcCtD
Ropivacaine—Hypersensitivity—Cisplatin—esophageal cancer	0.00104	0.00156	CcSEcCtD
Ropivacaine—Infection—Capecitabine—esophageal cancer	0.00103	0.00155	CcSEcCtD
Ropivacaine—Shock—Capecitabine—esophageal cancer	0.00102	0.00153	CcSEcCtD
Ropivacaine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00102	0.00152	CcSEcCtD
Ropivacaine—Tinnitus—Methotrexate—esophageal cancer	0.00101	0.00152	CcSEcCtD
Ropivacaine—Tachycardia—Capecitabine—esophageal cancer	0.00101	0.00152	CcSEcCtD
Ropivacaine—Asthenia—Cisplatin—esophageal cancer	0.00101	0.00151	CcSEcCtD
Ropivacaine—Cardiac disorder—Methotrexate—esophageal cancer	0.00101	0.00151	CcSEcCtD
Ropivacaine—Skin disorder—Capecitabine—esophageal cancer	0.00101	0.00151	CcSEcCtD
Ropivacaine—Hyperhidrosis—Capecitabine—esophageal cancer	0.001	0.0015	CcSEcCtD
Ropivacaine—Chills—Methotrexate—esophageal cancer	0.000975	0.00146	CcSEcCtD
Ropivacaine—Hypotension—Capecitabine—esophageal cancer	0.000969	0.00145	CcSEcCtD
Ropivacaine—Diarrhoea—Cisplatin—esophageal cancer	0.000963	0.00144	CcSEcCtD
Ropivacaine—Mental disorder—Methotrexate—esophageal cancer	0.000952	0.00143	CcSEcCtD
Ropivacaine—Erythema—Methotrexate—esophageal cancer	0.000946	0.00142	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000945	0.00142	CcSEcCtD
Ropivacaine—Insomnia—Capecitabine—esophageal cancer	0.000938	0.00141	CcSEcCtD
Ropivacaine—Paraesthesia—Capecitabine—esophageal cancer	0.000931	0.0014	CcSEcCtD
Ropivacaine—Dyspnoea—Capecitabine—esophageal cancer	0.000925	0.00139	CcSEcCtD
Ropivacaine—Back pain—Methotrexate—esophageal cancer	0.000915	0.00137	CcSEcCtD
Ropivacaine—Dyspepsia—Capecitabine—esophageal cancer	0.000913	0.00137	CcSEcCtD
Ropivacaine—Vomiting—Cisplatin—esophageal cancer	0.000895	0.00134	CcSEcCtD
Ropivacaine—Vision blurred—Methotrexate—esophageal cancer	0.000892	0.00134	CcSEcCtD
Ropivacaine—Rash—Cisplatin—esophageal cancer	0.000887	0.00133	CcSEcCtD
Ropivacaine—Constipation—Capecitabine—esophageal cancer	0.000887	0.00133	CcSEcCtD
Ropivacaine—Pain—Capecitabine—esophageal cancer	0.000887	0.00133	CcSEcCtD
Ropivacaine—Dermatitis—Cisplatin—esophageal cancer	0.000886	0.00133	CcSEcCtD
Ropivacaine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000878	0.00132	CcSEcCtD
Ropivacaine—Anaemia—Methotrexate—esophageal cancer	0.000874	0.00131	CcSEcCtD
Ropivacaine—Feeling abnormal—Capecitabine—esophageal cancer	0.000855	0.00128	CcSEcCtD
Ropivacaine—Malaise—Methotrexate—esophageal cancer	0.000853	0.00128	CcSEcCtD
Ropivacaine—Vertigo—Methotrexate—esophageal cancer	0.00085	0.00128	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000848	0.00127	CcSEcCtD
Ropivacaine—Nausea—Cisplatin—esophageal cancer	0.000836	0.00125	CcSEcCtD
Ropivacaine—Cough—Methotrexate—esophageal cancer	0.000826	0.00124	CcSEcCtD
Ropivacaine—Urticaria—Capecitabine—esophageal cancer	0.000824	0.00124	CcSEcCtD
Ropivacaine—Abdominal pain—Capecitabine—esophageal cancer	0.00082	0.00123	CcSEcCtD
Ropivacaine—Body temperature increased—Capecitabine—esophageal cancer	0.00082	0.00123	CcSEcCtD
Ropivacaine—Convulsion—Methotrexate—esophageal cancer	0.00082	0.00123	CcSEcCtD
Ropivacaine—Chest pain—Methotrexate—esophageal cancer	0.000805	0.00121	CcSEcCtD
Ropivacaine—Myalgia—Methotrexate—esophageal cancer	0.000805	0.00121	CcSEcCtD
Ropivacaine—Arthralgia—Methotrexate—esophageal cancer	0.000805	0.00121	CcSEcCtD
Ropivacaine—Discomfort—Methotrexate—esophageal cancer	0.000796	0.00119	CcSEcCtD
Ropivacaine—Confusional state—Methotrexate—esophageal cancer	0.000779	0.00117	CcSEcCtD
Ropivacaine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000772	0.00116	CcSEcCtD
Ropivacaine—Infection—Methotrexate—esophageal cancer	0.000767	0.00115	CcSEcCtD
Ropivacaine—Hypersensitivity—Capecitabine—esophageal cancer	0.000764	0.00115	CcSEcCtD
Ropivacaine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000756	0.00113	CcSEcCtD
Ropivacaine—Skin disorder—Methotrexate—esophageal cancer	0.00075	0.00113	CcSEcCtD
Ropivacaine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000746	0.00112	CcSEcCtD
Ropivacaine—Asthenia—Capecitabine—esophageal cancer	0.000744	0.00112	CcSEcCtD
Ropivacaine—Pruritus—Capecitabine—esophageal cancer	0.000734	0.0011	CcSEcCtD
Ropivacaine—Hypotension—Methotrexate—esophageal cancer	0.000722	0.00108	CcSEcCtD
Ropivacaine—Diarrhoea—Capecitabine—esophageal cancer	0.00071	0.00106	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000703	0.00106	CcSEcCtD
Ropivacaine—Insomnia—Methotrexate—esophageal cancer	0.000698	0.00105	CcSEcCtD
Ropivacaine—Paraesthesia—Methotrexate—esophageal cancer	0.000693	0.00104	CcSEcCtD
Ropivacaine—Dyspnoea—Methotrexate—esophageal cancer	0.000688	0.00103	CcSEcCtD
Ropivacaine—Somnolence—Methotrexate—esophageal cancer	0.000686	0.00103	CcSEcCtD
Ropivacaine—Dizziness—Capecitabine—esophageal cancer	0.000686	0.00103	CcSEcCtD
Ropivacaine—Dyspepsia—Methotrexate—esophageal cancer	0.00068	0.00102	CcSEcCtD
Ropivacaine—Pain—Methotrexate—esophageal cancer	0.00066	0.000991	CcSEcCtD
Ropivacaine—Vomiting—Capecitabine—esophageal cancer	0.00066	0.00099	CcSEcCtD
Ropivacaine—Rash—Capecitabine—esophageal cancer	0.000654	0.000981	CcSEcCtD
Ropivacaine—Dermatitis—Capecitabine—esophageal cancer	0.000653	0.00098	CcSEcCtD
Ropivacaine—Headache—Capecitabine—esophageal cancer	0.00065	0.000975	CcSEcCtD
Ropivacaine—Feeling abnormal—Methotrexate—esophageal cancer	0.000636	0.000955	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000631	0.000947	CcSEcCtD
Ropivacaine—Nausea—Capecitabine—esophageal cancer	0.000616	0.000925	CcSEcCtD
Ropivacaine—Urticaria—Methotrexate—esophageal cancer	0.000613	0.00092	CcSEcCtD
Ropivacaine—Abdominal pain—Methotrexate—esophageal cancer	0.00061	0.000916	CcSEcCtD
Ropivacaine—Body temperature increased—Methotrexate—esophageal cancer	0.00061	0.000916	CcSEcCtD
Ropivacaine—Hypersensitivity—Methotrexate—esophageal cancer	0.000569	0.000854	CcSEcCtD
Ropivacaine—Asthenia—Methotrexate—esophageal cancer	0.000554	0.000831	CcSEcCtD
Ropivacaine—Pruritus—Methotrexate—esophageal cancer	0.000546	0.00082	CcSEcCtD
Ropivacaine—Diarrhoea—Methotrexate—esophageal cancer	0.000528	0.000793	CcSEcCtD
Ropivacaine—Dizziness—Methotrexate—esophageal cancer	0.000511	0.000766	CcSEcCtD
Ropivacaine—Vomiting—Methotrexate—esophageal cancer	0.000491	0.000737	CcSEcCtD
Ropivacaine—Rash—Methotrexate—esophageal cancer	0.000487	0.000731	CcSEcCtD
Ropivacaine—Dermatitis—Methotrexate—esophageal cancer	0.000486	0.00073	CcSEcCtD
Ropivacaine—Headache—Methotrexate—esophageal cancer	0.000484	0.000726	CcSEcCtD
Ropivacaine—Nausea—Methotrexate—esophageal cancer	0.000459	0.000688	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—NOTCH1—esophageal cancer	0.000344	0.00106	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MET—esophageal cancer	0.000341	0.00106	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.000341	0.00105	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000341	0.00105	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000337	0.00104	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—ERBB2—esophageal cancer	0.000336	0.00104	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—ERBB2—esophageal cancer	0.000336	0.00104	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—KDR—esophageal cancer	0.000335	0.00104	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—KDR—esophageal cancer	0.000335	0.00104	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000332	0.00103	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—NOTCH1—esophageal cancer	0.000329	0.00102	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MET—esophageal cancer	0.000328	0.00101	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MET—esophageal cancer	0.000328	0.00101	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—ERBB2—esophageal cancer	0.000324	0.001	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—ERBB2—esophageal cancer	0.000324	0.001	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—KDR—esophageal cancer	0.000323	0.001	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—KDR—esophageal cancer	0.000323	0.001	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—ERBB2—esophageal cancer	0.000323	0.000998	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000321	0.000992	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—KDR—esophageal cancer	0.000318	0.000985	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000317	0.00098	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MET—esophageal cancer	0.000316	0.000978	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MET—esophageal cancer	0.000316	0.000978	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—NOTCH1—esophageal cancer	0.000316	0.000977	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—NOTCH1—esophageal cancer	0.000316	0.000977	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000314	0.000972	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—EGFR—esophageal cancer	0.000313	0.000969	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000313	0.000967	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MET—esophageal cancer	0.000312	0.000964	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—CREBBP—esophageal cancer	0.000312	0.000964	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—NOTCH1—esophageal cancer	0.000304	0.000942	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—NOTCH1—esophageal cancer	0.000304	0.000942	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.0003	0.000929	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ABL1—esophageal cancer	0.0003	0.000928	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CREBBP—esophageal cancer	0.000298	0.000922	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000296	0.000914	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000291	0.000899	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—SMAD4—esophageal cancer	0.00029	0.000898	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000287	0.000887	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CREBBP—esophageal cancer	0.000286	0.000886	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CREBBP—esophageal cancer	0.000286	0.000886	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	0.000286	0.000883	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.00028	0.000866	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CREBBP—esophageal cancer	0.000276	0.000854	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CREBBP—esophageal cancer	0.000276	0.000854	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	0.000272	0.00084	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.00027	0.000836	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	0.000268	0.00083	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000267	0.000825	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EP300—esophageal cancer	0.000262	0.000812	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000262	0.00081	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—ERBB2—esophageal cancer	0.000261	0.000807	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000255	0.00079	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	0.000254	0.000787	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—EGFR—esophageal cancer	0.000253	0.000784	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000252	0.000779	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—ERBB2—esophageal cancer	0.00025	0.000772	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000245	0.000757	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—EGFR—esophageal cancer	0.000242	0.00075	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.00024	0.000743	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ERBB2—esophageal cancer	0.00024	0.000742	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—ERBB2—esophageal cancer	0.00024	0.000742	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000237	0.000733	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000233	0.000721	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000233	0.000721	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—EGFR—esophageal cancer	0.000233	0.00072	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—EGFR—esophageal cancer	0.000233	0.00072	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—ERBB2—esophageal cancer	0.000231	0.000715	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ERBB2—esophageal cancer	0.000231	0.000715	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—ERBB2—esophageal cancer	0.000228	0.000705	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KDR—esophageal cancer	0.000227	0.000703	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—EGFR—esophageal cancer	0.000225	0.000695	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—EGFR—esophageal cancer	0.000225	0.000695	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EGFR—esophageal cancer	0.000224	0.000692	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MET—esophageal cancer	0.000222	0.000688	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.00022	0.000682	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.000216	0.000669	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NOTCH1—esophageal cancer	0.000214	0.000662	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000213	0.00066	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EP300—esophageal cancer	0.000212	0.000656	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.00021	0.000648	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000209	0.000646	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000207	0.000641	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.000203	0.000629	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000203	0.000628	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EP300—esophageal cancer	0.000203	0.000628	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000201	0.000621	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000199	0.000614	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000199	0.000614	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000196	0.000607	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EP300—esophageal cancer	0.000195	0.000603	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EP300—esophageal cancer	0.000195	0.000603	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CREBBP—esophageal cancer	0.000194	0.0006	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EP300—esophageal cancer	0.000188	0.000582	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EP300—esophageal cancer	0.000188	0.000582	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—BLVRB—esophageal cancer	0.000186	0.000574	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC52A3—esophageal cancer	0.000186	0.000574	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—esophageal cancer	0.000181	0.000559	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—esophageal cancer	0.000173	0.000535	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000167	0.000517	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—esophageal cancer	0.000166	0.000514	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—esophageal cancer	0.000166	0.000514	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000165	0.000509	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ERBB2—esophageal cancer	0.000163	0.000503	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—esophageal cancer	0.00016	0.000496	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—esophageal cancer	0.00016	0.000496	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—esophageal cancer	0.000158	0.000488	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CA1—esophageal cancer	0.000158	0.000488	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC10A2—esophageal cancer	0.000158	0.000488	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000157	0.000486	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000155	0.000479	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CA2—esophageal cancer	0.000144	0.000447	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000141	0.000436	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLCE1—esophageal cancer	0.000134	0.000415	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ADH7—esophageal cancer	0.000134	0.000415	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EP300—esophageal cancer	0.000132	0.000409	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000129	0.000399	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000129	0.000399	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000123	0.00038	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ADH1B—esophageal cancer	0.000118	0.000364	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—esophageal cancer	0.000113	0.000349	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TYMP—esophageal cancer	0.000112	0.000348	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CA1—esophageal cancer	0.00011	0.000339	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.00011	0.000339	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP26A1—esophageal cancer	0.000109	0.000338	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000109	0.000338	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000109	0.000338	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALOX15—esophageal cancer	0.000107	0.00033	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTO1—esophageal cancer	0.000102	0.000315	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TPI1—esophageal cancer	0.000102	0.000315	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CA2—esophageal cancer	0.0001	0.00031	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	9.77e-05	0.000302	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALDOB—esophageal cancer	9.75e-05	0.000302	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GAPDH—esophageal cancer	9.39e-05	0.00029	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLCE1—esophageal cancer	9.33e-05	0.000289	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ADH7—esophageal cancer	9.33e-05	0.000289	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CRABP1—esophageal cancer	9.3e-05	0.000288	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CA1—esophageal cancer	9.29e-05	0.000288	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC10A2—esophageal cancer	9.29e-05	0.000288	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GNG7—esophageal cancer	8.85e-05	0.000274	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CA2—esophageal cancer	8.5e-05	0.000263	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	8.44e-05	0.000261	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—BLVRB—esophageal cancer	8.44e-05	0.000261	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	8.31e-05	0.000257	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALDH2—esophageal cancer	8.29e-05	0.000257	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ADH1B—esophageal cancer	8.18e-05	0.000253	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ADH7—esophageal cancer	7.9e-05	0.000244	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLCE1—esophageal cancer	7.9e-05	0.000244	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTT1—esophageal cancer	7.89e-05	0.000244	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TYMP—esophageal cancer	7.82e-05	0.000242	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	7.81e-05	0.000242	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP2A6—esophageal cancer	7.8e-05	0.000241	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	7.6e-05	0.000235	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALOX15—esophageal cancer	7.41e-05	0.000229	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS1—esophageal cancer	7.39e-05	0.000229	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ENO1—esophageal cancer	7.39e-05	0.000229	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PSME1—esophageal cancer	7.28e-05	0.000225	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PSME2—esophageal cancer	7.28e-05	0.000225	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CA1—esophageal cancer	7.17e-05	0.000222	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	7.17e-05	0.000222	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TPI1—esophageal cancer	7.07e-05	0.000219	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTO1—esophageal cancer	7.07e-05	0.000219	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ADH1B—esophageal cancer	6.93e-05	0.000214	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALDOB—esophageal cancer	6.78e-05	0.00021	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TYMP—esophageal cancer	6.62e-05	0.000205	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CA2—esophageal cancer	6.56e-05	0.000203	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GAPDH—esophageal cancer	6.52e-05	0.000202	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CRABP1—esophageal cancer	6.47e-05	0.0002	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	6.44e-05	0.000199	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP1B1—esophageal cancer	6.28e-05	0.000194	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALOX15—esophageal cancer	6.28e-05	0.000194	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GNG7—esophageal cancer	6.15e-05	0.00019	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLCE1—esophageal cancer	6.1e-05	0.000189	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ADH7—esophageal cancer	6.1e-05	0.000189	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTO1—esophageal cancer	5.99e-05	0.000185	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TPI1—esophageal cancer	5.99e-05	0.000185	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP19A1—esophageal cancer	5.91e-05	0.000183	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALDH2—esophageal cancer	5.76e-05	0.000178	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALDOB—esophageal cancer	5.74e-05	0.000178	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GAPDH—esophageal cancer	5.53e-05	0.000171	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTT1—esophageal cancer	5.48e-05	0.00017	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CRABP1—esophageal cancer	5.48e-05	0.000169	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	5.42e-05	0.000168	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMOX1—esophageal cancer	5.39e-05	0.000167	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ADH1B—esophageal cancer	5.35e-05	0.000165	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GNG7—esophageal cancer	5.21e-05	0.000161	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCB1—esophageal cancer	5.18e-05	0.00016	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS1—esophageal cancer	5.14e-05	0.000159	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ENO1—esophageal cancer	5.14e-05	0.000159	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TYMP—esophageal cancer	5.11e-05	0.000158	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PSME2—esophageal cancer	5.06e-05	0.000157	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PSME1—esophageal cancer	5.06e-05	0.000157	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.97e-05	0.000154	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALDH2—esophageal cancer	4.88e-05	0.000151	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALOX15—esophageal cancer	4.85e-05	0.00015	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTT1—esophageal cancer	4.64e-05	0.000144	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.62e-05	0.000143	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TPI1—esophageal cancer	4.62e-05	0.000143	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	4.59e-05	0.000142	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.57e-05	0.000141	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALDOB—esophageal cancer	4.43e-05	0.000137	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	4.37e-05	0.000135	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ENO1—esophageal cancer	4.35e-05	0.000135	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS1—esophageal cancer	4.35e-05	0.000135	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PSME1—esophageal cancer	4.29e-05	0.000133	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PSME2—esophageal cancer	4.29e-05	0.000133	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.27e-05	0.000132	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.23e-05	0.000131	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	4.11e-05	0.000127	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GNG7—esophageal cancer	4.02e-05	0.000124	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.77e-05	0.000117	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMOX1—esophageal cancer	3.75e-05	0.000116	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.74e-05	0.000116	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	3.7e-05	0.000114	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCB1—esophageal cancer	3.6e-05	0.000111	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.58e-05	0.000111	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.54e-05	0.00011	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	3.48e-05	0.000108	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CREBBP—esophageal cancer	3.46e-05	0.000107	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ENO1—esophageal cancer	3.36e-05	0.000104	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.36e-05	0.000104	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PSME2—esophageal cancer	3.31e-05	0.000102	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PSME1—esophageal cancer	3.31e-05	0.000102	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMOX1—esophageal cancer	3.17e-05	9.82e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.11e-05	9.63e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NOS3—esophageal cancer	3.1e-05	9.58e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCB1—esophageal cancer	3.05e-05	9.43e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.86e-05	8.83e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS2—esophageal cancer	2.83e-05	8.76e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.68e-05	8.31e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.45e-05	7.58e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.4e-05	7.44e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—EP300—esophageal cancer	2.36e-05	7.29e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.35e-05	7.27e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.3e-05	7.13e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NOS3—esophageal cancer	2.15e-05	6.66e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.04e-05	6.3e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.97e-05	6.09e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NOS3—esophageal cancer	1.82e-05	5.64e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CA—esophageal cancer	1.74e-05	5.39e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.67e-05	5.16e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—EP300—esophageal cancer	1.64e-05	5.06e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.57e-05	4.86e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.41e-05	4.35e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—EP300—esophageal cancer	1.39e-05	4.29e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.29e-05	3.98e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.21e-05	3.75e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—EP300—esophageal cancer	1.07e-05	3.31e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.03e-05	3.17e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	7.92e-06	2.45e-05	CbGpPWpGaD
